475 related articles for article (PubMed ID: 16139449)
1. Management of post-menopausal vaginal atrophy and atrophic vaginitis.
Castelo-Branco C; Cancelo MJ; Villero J; Nohales F; Juliá MD
Maturitas; 2005 Nov; 52 Suppl 1():S46-52. PubMed ID: 16139449
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal vaginal atrophy and atrophic vaginitis.
Pandit L; Ouslander JG
Am J Med Sci; 1997 Oct; 314(4):228-31. PubMed ID: 9332260
[TBL] [Abstract][Full Text] [Related]
3. Atrophic vaginitis.
Stika CS
Dermatol Ther; 2010; 23(5):514-22. PubMed ID: 20868405
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of atrophic vaginitis.
Bachmann GA; Nevadunsky NS
Am Fam Physician; 2000 May; 61(10):3090-6. PubMed ID: 10839558
[TBL] [Abstract][Full Text] [Related]
6. Treatment of postmenopausal vaginal atrophy with 10-μg estradiol vaginal tablets.
Panay N; Maamari R
Menopause Int; 2012 Mar; 18(1):15-9. PubMed ID: 22393176
[TBL] [Abstract][Full Text] [Related]
7. Estrogen and its effect on vaginal atrophy in post-menopausal women.
Kelley C
Urol Nurs; 2007 Feb; 27(1):40-5. PubMed ID: 17390926
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
[TBL] [Abstract][Full Text] [Related]
9. The effect of vaginally administered genistein in comparison with hyaluronic acid on atrophic epithelium in postmenopause.
Le Donne M; Caruso C; Mancuso A; Costa G; Iemmo R; Pizzimenti G; Cavallari V
Arch Gynecol Obstet; 2011 Jun; 283(6):1319-23. PubMed ID: 20577750
[TBL] [Abstract][Full Text] [Related]
10. [Local estrogen therapy--clinical implications--2012 update].
Kokot-Kierepa M; Bartuzi A; Kulik-Rechberger B; Rechberger T
Ginekol Pol; 2012 Oct; 83(10):772-7. PubMed ID: 23383564
[TBL] [Abstract][Full Text] [Related]
11. Vaginal hormone therapy for urogenital and menopausal symptoms.
Ballagh SA
Semin Reprod Med; 2005 May; 23(2):126-40. PubMed ID: 15852198
[TBL] [Abstract][Full Text] [Related]
12. Vaginal estrogen preparations: a review of safety and efficacy for vaginal atrophy.
Crandall C
J Womens Health (Larchmt); 2002 Dec; 11(10):857-77. PubMed ID: 12626086
[TBL] [Abstract][Full Text] [Related]
13. Open, non-controlled clinical studies to assess the efficacy and safety of a medical device in form of gel topically and intravaginally used in postmenopausal women with genital atrophy.
Morali G; Polatti F; Metelitsa EN; Mascarucci P; Magnani P; Marrè GB
Arzneimittelforschung; 2006; 56(3):230-8. PubMed ID: 16618016
[TBL] [Abstract][Full Text] [Related]
14. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy.
Dugal R; Hesla K; Sørdal T; Aase KH; Lilleeidet O; Wickstrøm E
Acta Obstet Gynecol Scand; 2000 Apr; 79(4):293-7. PubMed ID: 10746845
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of vaginal suppositories for the treatment of the vaginal atrophy in postmenopausal women: an open, non-controlled clinical trial.
Costantino D; Guaraldi C
Eur Rev Med Pharmacol Sci; 2008; 12(6):411-6. PubMed ID: 19146203
[TBL] [Abstract][Full Text] [Related]
16. Local oestrogen for vaginal atrophy in postmenopausal women.
Suckling J; Lethaby A; Kennedy R
Cochrane Database Syst Rev; 2006 Oct; (4):CD001500. PubMed ID: 17054136
[TBL] [Abstract][Full Text] [Related]
17. Urogenital atrophy.
Calleja-Agius J; Brincat MP
Climacteric; 2009 Aug; 12(4):279-85. PubMed ID: 19387880
[TBL] [Abstract][Full Text] [Related]
18. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
Al-Baghdadi O; Ewies AA
Climacteric; 2009 Apr; 12(2):91-105. PubMed ID: 19117185
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of local estrogen therapy for urogenital atrophy.
Archer DF
Menopause; 2010; 17(1):194-203. PubMed ID: 19602990
[TBL] [Abstract][Full Text] [Related]
20. [Topical hormonal treatment and urogenital atrophy].
Sitruk-Ware R; Thomas JL
Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
